Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 15;56(4):2487-2496.
doi: 10.1021/acs.est.1c06316. Epub 2022 Jan 26.

Adipogenic Activity of Chemicals Used in Plastic Consumer Products

Affiliations

Adipogenic Activity of Chemicals Used in Plastic Consumer Products

Johannes Völker et al. Environ Sci Technol. .

Abstract

Bisphenols and phthalates, chemicals frequently used in plastic products, promote obesity in cell and animal models. However, these well-known metabolism-disrupting chemicals (MDCs) represent only a minute fraction of all compounds found in plastics. To gain a comprehensive understanding of plastics as a source of exposure to MDCs, we characterized the chemicals present in 34 everyday products using nontarget high-resolution mass spectrometry and analyzed their joint adipogenic activities by high-content imaging. We detected 55,300 chemical features and tentatively identified 629 unique compounds, including 11 known MDCs. Importantly, the chemicals extracted from one-third of the products caused murine 3T3-L1 preadipocytes to proliferate, and differentiate into adipocytes, which were larger and contained more triglycerides than those treated with the reference compound rosiglitazone. Because the majority of plastic extracts did not activate the peroxisome proliferator-activated receptor γ and the glucocorticoid receptor, the adipogenic effects are mediated via other mechanisms and, thus, likely to be caused by unknown MDCs. Our study demonstrates that daily-use plastics contain potent mixtures of MDCs and can, therefore, be a relevant yet underestimated environmental factor contributing to obesity.

Keywords: adipogenesis; endocrine-disrupting chemicals; metabolic disruptors; non-target chemical analysis; obesogens.

PubMed Disclaimer

Conflict of interest statement

The authors declare the following competing financial interest(s): L.Z. became an employee of the Food Packaging Forum (FPF) after this study was concluded. M.W. is an unremunerated member of the Scientific Advisory Board of the FPF and received travel support for attending annual SAB meetings. FPF is a Swiss foundation that enhances the scientific principles and recent scientific findings that are relevant to the topic of food contact chemicals and their health impacts on humans and the environment.

Figures

Figure 1
Figure 1
Image analysis example showing differentiated 3T3-L1 cells exposed to rosiglitazone (4.69 nM). (A) Merged brightfield and fluorescence images. Nuclei are stained with NucBlue (blue) and lipid with NileRed (red). (B) Corresponding object identification performed with CellProfiler. Nuclei are outlined in blue, cell boundaries in green, and adipocytes in red. Identified lipid droplets are shown as a solid color, and all lipid droplets associated with a given adipocyte are displayed in the same color. The images contain an example of a mature adipocyte (Mature).
Figure 2
Figure 2
Effect of rosiglitazone on (A) the adipocyte population and (B) the lipid droplet count (pooled data from four experiments). Effect of plastic extracts on (C) the adipocyte population and (D) the lipid droplet count in the highest noncytotoxic concentration. The highest noncytotoxic concentration was 3 mg plastics well–1 except for PP 4 (1.5 mg plastic well–1) as well as PUR 2 and PUR 3 (0.75 mg plastic well–1). VC = vehicle control, LOD = limit of detection, Rosi Max = maximal response of rosiglitazone.
Figure 3
Figure 3
(A) Size distribution of the adipocyte population and (B) accumulation of triglyceride per adipocyte in cells exposed to rosiglitazone (left) or the highest noncytotoxic concentration of the 11 active plastic extracts (right). Single-cell data from one experiment. Intensity data are normalized on the mean of the highest rosiglitazone concentration (300 nM). VC = vehicle control.
Figure 4
Figure 4
PPARγ activity induced by plastic extracts at the highest noncytotoxic concentration. The highest noncytotoxic concentration was 1.5 mg plastic well–1, except for PP 4 (0.19 mg plastic well–1), PS 2, and PP 3 (0.38 mg plastic well–1) as well as PLA 1 and PVC 2 (0.75 mg plastic well–1).

References

    1. Swinburn B. A.; Kraak V. I.; Allender S.; Atkins V. J.; Baker P. I.; Bogard J. R.; Brinsden H.; Calvillo A.; De Schutter O.; Devarajan R.; Ezzati M.; Friel S.; Goenka S.; Hammond R. A.; Hastings G.; Hawkes C.; Herrero M.; Hovmand P. S.; Howden M.; Jaacks L. M.; Kapetanaki A. B.; Kasman M.; Kuhnlein H. V.; Kumanyika S. K.; Larijani B.; Lobstein T.; Long M. W.; Matsudo V. K. R.; Mills S. D. H.; Morgan G.; Morshed A.; Nece P. M.; Pan A.; Patterson D. W.; Sacks G.; Shekar M.; Simmons G. L.; Smit W.; Tootee A.; Vandevijvere S.; Waterlander W. E.; Wolfenden L.; Dietz W. H. The global syndemic of obesity, undernutrition, and climate change: The Lancet Commission report. Lancet 2019, 393, 791–846. 10.1016/S0140-6736(18)32822-8. - DOI - PubMed
    1. World Health Organisation . Obesity and overweight. Fact sheet; World Health Organisation: Geneva, Switzerland, 2018.
    1. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017, 390, P1345–P1422. 10.1016/S0140-6736(18)32225-6. - DOI - PMC - PubMed
    1. Simmonds M.; Llewellyn A.; Owen C. G.; Woolacott N. Predicting adult obesity from childhood obesity: a systematic review and meta-analysis. Obes. Rev. 2016, 17, 95–107. 10.1111/obr.12334. - DOI - PubMed
    1. Health effects of overweight and obesity in 195 countries over 25 years. N. Engl. J. Med. 2017, 377, 13–27. 10.1056/NEJMoa1614362. - DOI - PMC - PubMed

Publication types